NAJEFF WASEEM
Medical Oncology Physician · BALTIMORE, MD
Individual Active NPI 1598119711
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 842 | 237,157 | $16,368,942 | $4,876,416 | $3,882,646 |
| 2023 | 562 | 146,097 | $8,897,501 | $2,521,638 | $2,006,547 |
| 2022 | 181 | 27,262 | $1,521,768 | $436,226 | $347,903 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 44,800 | $3 | $2 |
| J9299 | Injection, nivolumab, 1 mg | 28,560 | $31 | $25 |
| J9025 | Injection, azacitidine, 1 mg | 14,600 | $0 | $0 |
| J9263 | Injection, oxaliplatin, 0.5 mg | 13,900 | $0 | $0 |
| J0897 | Injection, denosumab, 1 mg | 13,620 | $26 | $21 |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase-fihj | 13,320 | $49 | $39 |
| J0185 | Injection, aprepitant, 1 mg | 8,060 | $2 | $1 |
| J1437 | Injection, ferric derisomaltose, 10 mg | 8,000 | $20 | $16 |
| J9271 | Injection, pembrolizumab, 1 mg | 8,000 | $56 | $45 |
| J9267 | Injection, paclitaxel, 1 mg | 6,126 | $0 | $0 |
| J1568 | Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | 2,130 | $47 | $38 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 2,037 | $0 | $0 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Medical Oncology Physician | 207RX0202X | ✓ | D88602 | MD |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Medical Oncology Physician providers in Maryland
- NPI 1427497551
- NPI 1124511092
- NPI 1114976065
- NPI 1164089843
- NPI 1780738229
- NPI 1184642548
- NPI 1770546830
- NPI 1063450989
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.